Heart Transplant Rejection Study Suggests Blood Test Adds Prognostic Insight Beyond Biopsy
GenomeWeb@genomeweb
First author Jeff Teuteberg said these results, "challenge the paradigm of biopsy alone as the gold standard for assessing graft injury."
Tech & routing
- Language
- English
Landing page
Operated by
Company info pending
Funnel
Capture in progress
We're still capturing the landing-page funnel for this creative. Check back in ~48h.
Landing page intelligence
genomeweb.com
Host
genomeweb.com
Path
/liquid-biopsy/heart-transplant-rejection-study-suggests-dual-marker-blood-testing-adds-prognostic
Full URL
Redirect chain
1 hop- finalgenomeweb.com
Landing page snapshot
Captured 2026-05-14
Tracking parameters
- utm_source
- outbrain
- utm_medium
- paid content
- utm_campaign
- genomeweb_caredx_april
- obOrigUrl
- true
+ 1 known tracker hidden (cloaker IDs scrubbed at ingest).
Tracking setup · Outbrain
Outbrain emits ob_click_id (your unique click), ob_source (publisher), ob_section (placement), and ob_position. Forward ob_click_id to your tracker as the postback key. ob_source and ob_section are the two highest-signal sub-IDs for blacklisting.
?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}Default Outbrain setup template: ?ob_click_id={ob_click_id}&ob_source={ob_source}&ob_section={ob_section}&ob_position={ob_position}